Therapy News and Research

RSS
New app helps patients with alcohol-related liver disease recover, saves lives

New app helps patients with alcohol-related liver disease recover, saves lives

St. Jude scientists develop novel spectinomycin derivatives to combat Mycobacterium abscessus

St. Jude scientists develop novel spectinomycin derivatives to combat Mycobacterium abscessus

Stapled lipopeptides show promise as broad-spectrum antiviral agents

Stapled lipopeptides show promise as broad-spectrum antiviral agents

Soft, wearable robot helps a person with Parkinson's to walk without freezing

Soft, wearable robot helps a person with Parkinson's to walk without freezing

Breakthrough drug halts lung cancer and brain metastases

Breakthrough drug halts lung cancer and brain metastases

40-year timeline of HIV: Testing assays, global burden, prevalence, treatment, and challenges

40-year timeline of HIV: Testing assays, global burden, prevalence, treatment, and challenges

Metabolically armored CAR-T cells demonstrate lasting efficacy against solid tumors

Metabolically armored CAR-T cells demonstrate lasting efficacy against solid tumors

Prevention of post-menopausal osteoporosis in rats by sesame oil

Prevention of post-menopausal osteoporosis in rats by sesame oil

Revolutionary RNA-based switch offers new control over gene expression in mammalian cells

Revolutionary RNA-based switch offers new control over gene expression in mammalian cells

Urban green and blue spaces linked to improved mental, physical health in older adults

Urban green and blue spaces linked to improved mental, physical health in older adults

Unmasking the persistent threats of long-COVID's pulmonary sequelae

Unmasking the persistent threats of long-COVID's pulmonary sequelae

Stanford Medicine researchers demonstrate new way to temporarily heighten hypnotizablity

Stanford Medicine researchers demonstrate new way to temporarily heighten hypnotizablity

PharmaKure granted MHRA Clinical Trial Authorisation (CTA) for PK051 for the treatment of mild cognitive impairment due to Alzheimer’s Disease

PharmaKure granted MHRA Clinical Trial Authorisation (CTA) for PK051 for the treatment of mild cognitive impairment due to Alzheimer’s Disease

Doctors are as vulnerable to addiction as anyone. California grapples with a response.

Doctors are as vulnerable to addiction as anyone. California grapples with a response.

New approach leverages macrophages to treat traumatic brain injury

New approach leverages macrophages to treat traumatic brain injury

Combination therapy of dapagliflozin and semaglutide shows superior efficacy in type 2 diabetes management

Combination therapy of dapagliflozin and semaglutide shows superior efficacy in type 2 diabetes management

Factors that increase the risk of severe COVID-19 in children

Factors that increase the risk of severe COVID-19 in children

EZH2 inhibitors show promise in regenerating insulin-producing cells for type 1 diabetes treatment

EZH2 inhibitors show promise in regenerating insulin-producing cells for type 1 diabetes treatment

Study provides new insights into the treatment of obstructive sleep apnea

Study provides new insights into the treatment of obstructive sleep apnea

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.